GlassScriptPhysician profile
James Patrick Owen
NPI 1144299355
$73,327.25
in general payments reported to CMS, 2019-2025
10 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46K · 2021: $27K · 2022: $238 · 2023: $48.47 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $171.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $45,972.91 | 2019-2023 | Clareon |
| Alcon Research LLC | $26,434.01 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $238.30 | 2022 | |
| Sun Pharmaceutical Industries INC. | $150.00 | 2019 | |
| Mallinckrodt Enterprises LLC | $137.59 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $124.99 | 2021 | |
| Glaukos Corporation | $122.74 | 2025 | Istent Infinite, Idosetr, Kxl System (Not Refurbished) |
| Carl Zeiss Meditec, INC. | $104.87 | 2019 | |
| Kala Pharmaceuticals, INC. | $22.41 | 2021 | |
| Mallinckrodt Hospital Products INC. | $19.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Owen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.